Determinants of willingness to pay taxes for a community-based prevention programme

Scandinavian Journal of Public Health

Volumn 25, Issue 2, 1997, Pages 126-135

  Lindholm, Lars A ^a   Rosén, Måns E ^b   Stenbeck, Magnus E ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b CENTRE FOR EPIDEMIOLOGY   (Sweden)

Author keywords

community based prevention; willingness to pay

Indexed keywords

ADULT; ANXIETY; ARTICLE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; EXPECTATION; FEMALE; HEALTH CARE COST; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MALE; MORTALITY; NORMAL HUMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SWEDEN; TAX;

EID: 26844538255     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/140349489702500210     Document Type: Article

References (44)

1. Altman D., Flora J., Fortman S., Farquhar J. The Cost-effectiveness of three Smoking Cessation Programmes. AJPH 1987; 77: 162-5.
2. Nelson D., Lasater T., Niknian M., Carleton R. Cost effectiveness of different recruitment strategies for self-help smoking cessation programs. Health Education Research 1989: 4: 79-85.
3. Nissinen A., Tuomilehto J., Kottke T., Puska P. Cost-effectiveness of the North Karelia Hypertension Program 1972–1977. Med Care 1986; 24: 767-781.
4. Nissinen A., Tuomilehto J., Enlund H., Kottke T. Costs and benefits of community programmes for the control of hypertension. Journal of Human Hypertension 1992; 6: 473-9.
5. Kottke T., Puska P., Feldman R., Salonen J., Tuomilehto J. A decline in earning losses associated with a community-based cardiovascular disease prevention project. Med Care 1982; 20: 663-675.
6. Phillips C., Prowle M. Economics of a reduction in smoking: case study from Heartbeat Wales. J Epidemiol Community Health 1993; 47: 215-223.
7. Cohen D., Henderson J. Health, Prevention and Economics. Oxford: Oxford Medical Publications, 1988.
8. Cohen D. Health promotion and cost-effectiveness. Health Promotion International 1994; 9: 281-7.
9. Rosén M., Lindholm L. The neglected effects of lifestyle interventions in cost-effectiveness analysis. Health Promotion International 1992; 7: 163-9.
10. Berwick D., Weinstein M. What do patients value? Willingness to pay for ultrasound in normal pregnancy. Med Care 1985; 23: 881-893.
11. Hatziandreu E., Koplan J., Weinstein M. et al. A Cost-effectiveness Analysis of Exercise as a Health Promotion Activity. AJPH 1988; 78: 224-229.
12. Gram I., Lund E., Stenker S. Quality of life following a false positive mammogram. Br J Cancer 1990; 62: 1018-1022.
13. Haynes R., Sacket D., Taylor W., Gibson E., Johnson A. Increased absenteeism from work after detection and labelling of hypertensive patients. New Engl J Med 1978; 299: 741-4.
14. Cairns J., Shackley P. Sometimes sensitive, seldom specific: A review of the economics of screening. Health Economics 1993; 2: 43-53.
15. Mitchell R., Carson R. Using Surveys to Value Public Goods: The Contingent Valuation Method. Washington D.C.: Resources for the Future, 1990.
16. Hausman J. (eds) Contingent Valuation- A Critical Assessment. Amsterdam: North-Holland, 1993.
17. Brännström I., Rosén M., Wall S., Weinehall L. Local health planning and intervention–The case of a Swedish municipality. Scand J Prim Health Care 1988; suppll: 57-64.
18. Johannesson M., Jönsson B. Economic evaluation in health care: Is there a role for cost-benefit analysis? Health Policy 1991; 17: 1-23.
19. Acton P. Evaluating Public Programmes to Save Lives: The Case of Heart Attacks. Santa Monica: Rand, 1973.
20. Appel L., Steinberg E., Powe N., Anderson G., Dwyer S., Faden R. Risk Reduction From Low Osmolality Contrast Media. What Do Patients Think It Is Worth?. Med Care 1990; 28: 324-337.
21. Donaldson C. Willingness to pay for public-provided goods: A possible measure of benefit? J Health Econ 1990; 9: 103-118.
22. Gafni A. Willingness-to-Pay as a Measure of Benefits. Relevant Questions in the Context of Public Decision making About Health Care Programmes. Med Care 1991; 29: 1246-1252.
23. Johannesson M., Jönsson B., Borgquist L. Willingness to pay for antihypertensive therapy–results of a Swedish pilot study. J Health Econ 1991; 10: 461-474.
24. Johannesson M., Åberg H., Agréus L., Borgquist L., Jönsson B. Cost-benefit analysis of non-pharmacological treatment of hypertension. J Internal Med 1991; 230: 307-312.
25. Johannesson, M. et al. Willingness to pay for antihypertensive therapy–further aspects. J Health Econ 1993; 12: 95-108.
26. Rice D., et al. Cost of Injury in the United States: A Report to Congress. Institute for Health and Ageing, University of California, San Francisco and Injury Prevention Centre, The John Hopkins University, 1989.
27. Thompson M. Willingness to Pay and Accept Risks to Cure Chronic Disease. AJPH 1986; 76: 392-6.
28. Brännström I., Lindblad I. Mass Communication and Health Promotion; The Power of the Media and Public Opinion. Health Communication 1994; 6: 21-36.
29. Lindholm L., Rosén M., Weinehall L., Asplund K. Cost-effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden. J Epidemiol Community Health 1996; 50: 190-5.
30. Lindholm L. Rosén M, Hellsten G. Are people willing to pay for a community-based preventive programme?-A case study from Norsjö, Sweden. Int J of Technol Assess Health Care 1994; 10: 317-324.
31. Bollen K., Jackman R. Regression Diagnostics: An Expository Treatment of Outliers and Influential Cases. Newbury Park CA: Sage, 1990.
32. Pindyck R., Rubinfeld D. Econometric models and economic forecasts. Singapore; McGraw-Hill, 1991.
33. Cody R., Smith J. Applied Statistics and the SAS Programming Language. New York: North-Holland, 1991.
34. Freund R., Litell R. SAS System for Regression. Cary NC; SAS Institute Inc., 1991.
35. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. BMJ 1994; 308: 362-372.
36. McFadden D., Leonard G. Issues in the Contingent Valuation of Environmental Goods: Methodologies for Data Collection and Analysis. In: Hausman J, ed. Contingent Valuation- A Critical Assessment. Amsterdam: North-Holland, 1993.
37. NOAA, Report of the NOAA (National Oceanic and Atmospheric Administration) Panel on Contingent Valuation, Department of Commerce, US, 1993.
38. Kemp M., Maxwell C. Exploring a Budget Context for Contingent Valuation Estimates. In: Hausman J, ed. Contingent Valuation-A Critical Assessment. Amsterdam: North-Holland, 1993.
39. Torrance G. Measurement of Health State Utilities for Economic Appraisal. J Health Econ 1986; 5: 1-30.
40. Arrow K. Uncertainty and the Welfare Economics of medical care. The American Economic Review 1963; LIII: 943-973.
41. Evans R. Strained mercy. Toronto: Butterworths, 1984.
42. Jones-Lee M. Paternalistic Altruism and the Value of Statistical Life. The Economic Journal 1992; 102: 80-90.
43. Johansson P-O. Altruism and the value of statistical life: empirical implications. J Health Econ 1994; 13: 111-118.
44. Sen A. Rational Fools: A Critique of Behavioural Foundations of Economic Theory. Ethics, 1977; 6: 317-344.